Regencell Bioscience Holdings Ltd (RGC) Stock Could Soon Reward Patient Investors

Regencell Bioscience Holdings Ltd (NASDAQ: RGC) is 18726.34% higher on its value in year-to-date trading and has touched a low of $0.08 and a high of $83.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RGC stock was last observed hovering at around $22.99 in the last trading session, with the day’s loss setting it -4.56%.

Currently trading at $18.43, the stock is -30.18% and 13.74% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.66 million and changing -19.83% at the moment leaves the stock 333.49% off its SMA200. RGC registered 14076.92% gain for a year compared to 6-month gain of 14076.92%. The firm has a 50-day simple moving average (SMA 50) of $16.202997 and a 200-day simple moving average (SMA200) of $4.251543.

The stock witnessed a 11.15% loss in the last 1 month and extending the period to 3 months gives it a 2782.06%, and is 5.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 60.69% over the week and 46.51% over the month.

Regencell Bioscience Holdings Ltd (RGC) has around 12 employees, a market worth around $9.11B and $0.00M in sales. Distance from 52-week low is 23013.53% and -77.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-60.89%).

.

Regencell Bioscience Holdings Ltd (RGC) Top Institutional Holders

7.0 institutions hold shares in Regencell Bioscience Holdings Ltd (RGC), with institutional investors hold 1.10% of the company’s shares. The shares outstanding are 494.49M, and float is at 30.48M with Short Float at 3.45%. Institutions hold 0.07% of the Float.

The top institutional shareholder in the company is UBS GROUP AG with over 312.0 shares valued at $1048.0. The investor’s holdings represent 0.0024% of the RGC Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 238.0 shares valued at $800.0 to account for 0.0018 of the shares outstanding.

Regencell Bioscience Holdings Ltd (RGC) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.